GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $221,000 | +8.9% | 6,373 | -8.1% | 0.00% | – |
| Q4 2021 | $203,000 | -43.8% | 6,935 | -51.1% | 0.00% | – |
| Q3 2021 | $361,000 | +28.5% | 14,170 | +76.7% | 0.00% | – |
| Q2 2021 | $281,000 | -29.6% | 8,020 | -18.2% | 0.00% | – |
| Q1 2021 | $399,000 | -17.9% | 9,802 | -12.7% | 0.00% | -100.0% |
| Q4 2020 | $486,000 | -31.0% | 11,222 | -12.1% | 0.00% | 0.0% |
| Q3 2020 | $704,000 | -43.2% | 12,760 | -35.1% | 0.00% | -50.0% |
| Q2 2020 | $1,240,000 | +43.5% | 19,646 | +16.1% | 0.00% | +100.0% |
| Q1 2020 | $864,000 | -50.1% | 16,918 | -22.3% | 0.00% | -50.0% |
| Q4 2019 | $1,730,000 | +104.7% | 21,763 | +24.9% | 0.00% | +100.0% |
| Q3 2019 | $845,000 | +74.2% | 17,425 | +89.1% | 0.00% | 0.0% |
| Q2 2019 | $485,000 | – | 9,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |